- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00187785
Doctor-Patient Communication in Spanish
January 13, 2006 updated by: University of California, San Francisco
Does use of a translator or use of less than perfect Spanish diminish provider-patient communication compared to a native speaker.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Spanish speaking drop-in patients will be consented then randomized to receive care by a native Spanish speaker, an English speaker using a translator, or an English speaker with intermediate Spanish skills using Spanish.
After the visit, the researcher will enquire about patient satisfaction, when the next appointment is, whether medication has been changed, and what instructions their provider gave them.
Each provider will do a similar questionnaire.
A blinded researcher will score a concordance of plans between provider and patient to see if there is a significant difference in retained information between the groups.
Study Type
Interventional
Enrollment
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Fresno, California, United States, 93702
- UMC Family Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Spanish speaker
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Educational/Counseling/Training
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
retention of medical information
|
Secondary Outcome Measures
Outcome Measure |
---|
patient satisfaction
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Roger B Mortimer, MD, Department of Family Practice
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2005
Study Completion
December 1, 2006
Study Registration Dates
First Submitted
September 14, 2005
First Submitted That Met QC Criteria
September 15, 2005
First Posted (Estimate)
September 16, 2005
Study Record Updates
Last Update Posted (Estimate)
January 18, 2006
Last Update Submitted That Met QC Criteria
January 13, 2006
Last Verified
August 1, 2005
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UMC200552
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on Spanish speaker level
-
Hennepin Healthcare Research InstituteNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsActive, not recruitingDiabetes Mellitus, Type 2United States
-
Oregon Research Behavioral Intervention Strategies...RecruitingConduct Disorder | Oppositional Defiant DisorderUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Recruiting
-
Carlos Robles-MedrandaCompletedGastroesophageal Reflux Disease and Esophageal Motility DisordersEcuador
-
New York UniversitySt. Luke's-Roosevelt Hospital CenterCompletedHIV InfectionsUnited States
-
Medstar Health Research InstituteMedia RezRecruiting
-
University of California, Los AngelesCompleted
-
University of BarcelonaUniversity of BurgosRecruiting
-
Instituto de Investigación Sanitaria de la Fundación...Recruiting